Rejection After Lung Transplant: Causes, Symptoms & Treatment

A lung transplant offers a new lease on life for patients with end-stage lung diseases such as pulmonary fibrosis, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, cystic fibrosis, and bronchiectasis. While advances in surgical techniques, immunosuppressive medications, and post-transplant care have significantly improved survival rates, one of the most important challenges after surgery is lung transplant rejection.

Rejection is a natural immune response in which the body's defense system recognizes the transplanted lung as foreign and attempts to attack it. Although this may sound alarming, rejection is not uncommon and can often be managed successfully if detected early and treated promptly.

Understanding the causes, warning signs, diagnosis, and treatment options for lung transplant rejection can help patients seek timely medical attention and protect the health of their transplanted lungs.

What Is Lung Transplant Rejection?

Lung transplant rejection occurs when the recipient's immune system identifies the donor lung as a foreign organ and launches an immune response against it. Even when donor-recipient matching is carefully performed, the immune system can still recognize differences between the donor and recipient tissues.

To prevent rejection, lung transplant recipients must take lifelong immunosuppressive medications. These medicines reduce the immune response, allowing the transplanted lung to function normally while minimizing the risk of rejection.

Rejection can occur days, months, or even years after transplantation, making regular follow-up essential throughout a patient's lifetime.

Why Does Lung Transplant Rejection Occur?

The immune system is designed to protect the body from bacteria, viruses, and other foreign substances. Unfortunately, it cannot always distinguish a transplanted organ from harmful invaders.

Common factors that contribute to rejection include:

• Natural immune response against donor tissue
• Missing or irregular intake of immunosuppressive medications
• Certain infections that stimulate the immune system
• Poor medication absorption
• Drug interactions that reduce immunosuppressant effectiveness
• Development of antibodies against the donor lung

Although rejection cannot always be prevented, careful monitoring and adherence to treatment significantly reduce the risk.

Types of Lung Transplant Rejection

Understanding the different types of lung transplant rejection helps guide treatment and long-term management.

1. Hyperacute Rejection

Hyperacute rejection is extremely rare due to modern donor screening and tissue matching.

It occurs:

• Within minutes or hours after transplantation
• Due to pre-existing antibodies against the donor organ
• Requires immediate medical intervention

Fortunately, this type of rejection is now uncommon because of improved transplant protocols.

2. Acute Cellular Rejection

Acute cellular rejection is the most common form of rejection.

It may develop:

• Within the first few months after transplantation
• At any time during the patient's life
• Even in patients taking regular medications

Many episodes are mild and reversible when diagnosed early.

3. Antibody-Mediated Rejection (AMR)

In this type, antibodies produced by the immune system attack the transplanted lung.

AMR can:

• Cause inflammation
• Damage lung blood vessels
• Reduce oxygen exchange
• Affect long-term transplant survival

Specialized laboratory testing is often required for diagnosis.

4. Chronic Lung Transplant Rejection

Chronic rejection develops gradually over months or years and remains one of the causes of long-term graft dysfunction.

It is commonly associated with Chronic Lung Allograft Dysfunction (CLAD), which may present as:

• Bronchiolitis Obliterans Syndrome (BOS)
• Restrictive Allograft Syndrome (RAS)

Early recognition and close monitoring are essential to slow disease progression.

Who Is at Higher Risk?

Although rejection can affect any transplant recipient, certain factors increase the likelihood.

Risk factors include:

• Younger age
• Previous episodes of rejection
• Irregular medication use
• Frequent respiratory infections
• Gastroesophageal reflux disease (GERD)
• Poor donor-recipient matching
• Formation of donor-specific antibodies

Patients with these risk factors require closer follow-up.

Symptoms of Lung Transplant Rejection

One of the biggest challenges is that rejection may initially cause very few symptoms. Some patients feel completely well despite early rejection.

Common symptoms include:

• Increasing shortness of breath
• Persistent cough
• Fever
• Fatigue
• Reduced exercise tolerance
• Chest discomfort
• Decreased oxygen levels
• Reduced lung function on spirometry
• Declining peak flow readings
• Unexplained weight loss in chronic rejection

Because these symptoms can resemble infection, prompt evaluation by the transplant team is essential.

When Should You Contact Your Transplant Team?

Seek immediate medical attention if you notice:

• Sudden worsening breathlessness
• Fever above 38°C
• Persistent cough
• Oxygen saturation lower than usual
• Reduced home spirometry readings
• Difficulty performing daily activities
• Swelling or unexplained fatigue

Never stop or adjust immunosuppressive medications without consulting your transplant specialist.

How Is Lung Transplant Rejection Diagnosed?

Early diagnosis significantly improves treatment success.

Evaluation may include:

Clinical Assessment

Doctors review symptoms, physical examination findings, oxygen levels, and medication history.

Pulmonary Function Tests

Spirometry helps identify declining lung function before significant symptoms develop.

Even small reductions in lung capacity may indicate early rejection.

Chest Imaging

Chest X-rays and high-resolution CT scans help detect:

• Lung inflammation
• Fluid accumulation
• Infection
• Structural abnormalities

Imaging also helps rule out other causes of symptoms.

Bronchoscopy with Lung Biopsy

Bronchoscopy remains one of the most important tools for diagnosing rejection.

During the procedure:

• A thin flexible camera is inserted into the airways.
• Small tissue samples are collected from the transplanted lung.
• The biopsy is examined under a microscope to identify rejection.

Blood Tests

Laboratory investigations may include:

• Drug level monitoring
• Infection screening
• Detection of donor-specific antibodies
• Routine blood counts
• Kidney and liver function tests

Treatment for Lung Transplant Rejection

Treatment depends on the type and severity of rejection.

High-Dose Corticosteroids

Mild to moderate acute rejection is commonly treated with intravenous corticosteroids followed by gradual dose reduction.

Many patients respond well to this treatment.

Adjustment of Immunosuppressive Medications

Doctors may:

• Increase medication doses
• Change to alternative immunosuppressants
• Add additional immune-modulating medications
• Monitor blood levels more closely

Medication adjustments are individualized for each patient.

Plasma Exchange (Plasmapheresis)

For antibody-mediated rejection, plasma exchange helps remove harmful antibodies from the bloodstream.

This treatment is often combined with other therapies.

Intravenous Immunoglobulin (IVIG)

IVIG helps regulate immune system activity and is commonly used alongside plasma exchange for antibody-mediated rejection.

Advanced Biological Therapies

Selected patients may receive targeted treatments such as monoclonal antibodies to suppress specific immune responses responsible for rejection.

These therapies are used in specialized transplant centers based on individual patient needs.

Treatment of Underlying Infections

Because infections and rejection can occur together, appropriate antibiotics, antivirals, or antifungal medications may also be required.

Can Lung Transplant Rejection Be Prevented?

Although rejection cannot always be avoided, patients can significantly reduce the risk by following their treatment plan.

Important preventive measures include:

• Taking immunosuppressive medications exactly as prescribed
• Never missing medication doses
• Attending regular follow-up appointments
• Performing home spirometry if advised
• Reporting new symptoms immediately
• Practicing good hand hygiene
• Avoiding exposure to respiratory infections
• Receiving recommended vaccinations
• Maintaining a healthy lifestyle

Patient education plays a major role in preventing severe rejection episodes.

Life After a Lung Transplant

Living with a transplanted lung requires lifelong commitment.

Patients should:

• Follow medication schedules consistently
• Exercise regularly under medical guidance
• Eat a balanced diet
• Avoid smoking and tobacco exposure
• Monitor blood pressure, weight, and blood sugar
• Maintain good oral hygiene
• Keep all scheduled follow-up visits

With proper care, many lung transplant recipients return to work, travel, exercise, and enjoy an improved quality of life.

Why Early Detection Matters

The earlier lung transplant rejection is diagnosed, the greater the likelihood of preserving lung function.

Delayed treatment may lead to:

• Permanent lung damage
• Chronic rejection
• Reduced transplant survival
• Respiratory failure
• Need for re-transplantation in selected cases

Regular monitoring remains one of the most effective ways to protect transplanted lungs.

Consult Prof. (Dr.) Arvind Kumar for Expert Lung Transplant Care in Gurgaon & Delhi

If you or a loved one has undergone a lung transplant or is experiencing symptoms that may indicate lung transplant rejection, seeking timely medical attention is essential. Early diagnosis and prompt treatment can help preserve the function of the transplanted lung and improve long-term outcomes.

Prof. (Dr.) Arvind Kumar is a thoracic surgeon with extensive expertise in lung transplantation and the management of complex thoracic conditions. Patients receive comprehensive care—from pre-transplant evaluation and surgery to long-term follow-up and the management of post-transplant complications—through a multidisciplinary approach tailored to their individual needs.

Whether you are looking for expert lung transplant care in Gurgaon or wish to consult a specialist for lung transplant treatment in Delhi, you can schedule a consultation with Prof. (Dr.) Arvind Kumar to receive a personalized evaluation and guidance based on your condition.

Book your consultation today to take the next step toward better lung health with expert thoracic care.

Conclusion

Lung transplant rejection remains one of the most significant challenges after transplantation, but advances in immunosuppressive therapy, diagnostic techniques, and long-term monitoring have greatly improved patient outcomes. Understanding the different types of rejection, recognizing early symptoms, and seeking prompt medical care are essential for protecting the transplanted lungs.

For lung transplant patients, lifelong adherence to medications, regular follow-up visits, and close communication with the transplant team are the foundation of successful long-term care. With timely intervention and expert multidisciplinary management, many episodes of rejection can be effectively controlled, allowing patients to enjoy improved lung function, greater independence, and a better quality of life after transplantation.